A firestorm erupted this week in response to the pharmaceutical company Mylan’s sharp increase in the price of its EpiPen, a life-saving treatment for severe allergic reactions. The company quickly backtracked, announcing a rebate plan. Here, three Northeastern faculty members—pharmacist Tayla Rose, healthcare finance expert Steven Pizer, and health policy researcher Gary Young—explain the clinical, economic, and policy implications of the controversy.
Through Northeastern’s population health doctoral program, Cassidy Griffin combines her doctoral studies with research at MEDITECH, a Massachusetts-based health information company. In so doing, she is learning how to conduct both discovery– and innovation-driven research on how population health and data analytics can help organizations improve efficiency and effectiveness of healthcare delivery.
Two Northeastern faculty members are examining healthcare providers ’ attitudes and behaviors toward implementing increasingly widespread payment reforms.
Northeastern last week convened an interdisciplinary group of national experts to discuss cutting-edge research and methodological breakthroughs in healthcare organization and management science.
Professor Gary Young and his colleagues at Northeastern are the first in the nation to analyze hospitals’ community benefits practices, which are intimately linked with their tax-exempt status.
Professor Gary Young has been selected to serve on the Internal Revenue Service’s Advisory Committee on Tax Exempt and Government Entities.
Terry Fulmer, dean of the Bouvé College of Health Sciences, led a faculty briefing on health-care policy at the Massachusetts State House on Thursday.